3417 — Ohki Healthcare Holdings Co Income Statement
0.000.00%
- ¥19bn
- ¥29bn
- ¥349bn
- 64
- 92
- 76
- 93
Annual income statement for Ohki Healthcare Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 270,927 | 278,162 | 304,445 | 334,661 | 349,452 |
| Cost of Revenue | |||||
| Gross Profit | 15,512 | 13,725 | 15,882 | 17,201 | 18,510 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 268,098 | 277,641 | 302,382 | 332,414 | 346,865 |
| Operating Profit | 2,829 | 521 | 2,063 | 2,247 | 2,587 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4,060 | 1,531 | 3,182 | 3,405 | 3,832 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,847 | 926 | 2,184 | 2,127 | 2,644 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,751 | 971 | 2,183 | 2,210 | 2,640 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,750 | 972 | 2,182 | 2,210 | 2,639 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 207 | 76.5 | 159 | 155 | 205 |
| Dividends per Share |